INSP
Inspire Medical Systems, Inc.
NYSE · Healthcare · Medical - Devices · US
$63.08
+1.51%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 898.7M | 912.0M | 802.8M | 624.8M | 407.9M |
| Cost of Revenue | 124.6M | 133.2M | 123.0M | 96.6M | 66.1M |
| Gross Profit | 774.1M | 778.8M | 679.8M | 528.2M | 341.7M |
| Operating Expenses | |||||
| R&D Expense | 99.7M | 103.2M | 114.1M | 116.5M | 68.6M |
| SG&A Expense | 620.3M | 624.6M | 529.6M | 452.0M | 320.7M |
| General & Admin Expense | 122.5M | — | 434.7M | 351.7M | 246.4M |
| Selling & Marketing Expense | 36.4M | — | 94.9M | 100.3M | 74.3M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 720.0M | 727.8M | 643.7M | 568.5M | 389.3M |
| Cost and Expenses | 844.6M | 861.0M | 766.7M | 665.1M | 455.4M |
| Operating Income (EBIT) | 54.1M | 51.0M | 36.1M | (40.3M) | (47.6M) |
| Non-Operating | |||||
| Interest Income | 15.5M | 17.5M | 23.2M | 20.6M | 5.0M |
| Interest Expense | 133.0K | 137.0K | 22.0K | — | 1.7M |
| Net Interest Income | 15.3M | 17.4M | 23.2M | 20.6M | 3.4M |
| Other Non-Op Income/Expense | 15.3M | 14.7M | 22.4M | 20.4M | 3.3M |
| Non-Operating Income (excl Interest) | (11.8M) | (14.9M) | (22.4M) | (20.4M) | (5.0M) |
| EBT (Pre-Tax Income) | 69.4M | 65.7M | 58.5M | (19.9M) | (44.3M) |
| Income Tax Expense | (65.7M) | (79.7M) | 4.9M | 1.2M | 613.0K |
| Bottom Line | |||||
| Net Income | 135.0M | 145.4M | 53.5M | (21.2M) | (44.9M) |
| Earnings from Cont. Ops | 135.0M | 145.4M | 53.5M | (21.2M) | (44.9M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 135.0M | 145.4M | 53.5M | (21.2M) | (44.9M) |
| Per Share | |||||
| Basic EPS | $4.66 | $4.95 | $1.80 | ($0.72) | ($1.60) |
| Diluted EPS | $4.62 | $4.89 | $1.75 | ($0.72) | ($1.60) |
| Revenue Per Share | $31.17 | $31.05 | $26.97 | $21.32 | $14.53 |
| Shares | |||||
| Basic Shares Outstanding | 28.8M | 29.4M | 29.8M | 29.3M | 28.1M |
| Diluted Shares Outstanding | 28.9M | 29.8M | 30.5M | 29.3M | 28.1M |
| Profitability Metrics | |||||
| EBITDA | 83.1M | 79.8M | 65.0M | (17.1M) | (40.7M) |
| D&A | 17.2M | 14.0M | 6.5M | 2.8M | 1.9M |
| EBIT | 65.9M | 65.8M | 58.5M | (19.9M) | (42.6M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026